Education
About Us
Working with TipRanks
Follow Us
BridgeBio Oncology Therapeutics (BBOT)
NASDAQ:BBOT
BridgeBio Oncology Therapeutics (BBOT) has received a new Buy rating, initiated by Morgan Stanley analyst, Sean Laaman. Sean Laaman has given his Buy rating due to a combination of factors
...Read more
BBOT News on the Web
AAII
Neutral
AAII
Neutral
AAII
Neutral
AAII
Neutral
AAII
Neutral
AAII
Neutral
AAII
Neutral
AAII
Neutral
News Score - Last 7 Days
Media Buzz
This Week2 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average55%
See how Bullish or Bearish a stock is based on its recent media coverage.
This score is generated using a formula that combines Media Buzz and News Sentiment.
This score is generated using a formula that combines Media Buzz and News Sentiment.
Media Coverage Analysis
The historical news coverage of this asset in the last three months.
FAQ
What is BBOT’s Media Buzz Sentiment?
2 articles about BBOT were published this week. In an average week, 1 articles are published.
What is BBOT’s weekly average amount of articles?
In an average week, 1 articles about BBOT are published.
What is BBOT’s News Sentiment?
50% of articles about BBOT were positive this week, compared to its sector average of 55%.